Richard A. Andrews
Direttore/Membro del Consiglio presso ProThera Biologics, Inc.
Profilo
Richard A.
Andrews was the founder of RenaMed Biologics, Inc. (1995) and Azitra, Inc. (2017), where he held the titles of Chief Executive Officer and President, Chief Executive Officer & Director, respectively.
Currently, he is a Director at ProThera Biologics, Inc. In the past, he served as President, Chief Executive Officer & Director at Thrasos Therapeutics, Inc., Head-Clinical Operations at Vasca, Inc., and Chief Business Officer at ProThera Biologics, Inc. Mr. Andrews has a graduate degree from Massachusetts Institute of Technology and Purdue University, and an undergraduate degree from Hobart & William Smith Colleges.
Posizioni attive di Richard A. Andrews
| Società | Posizione | Inizio |
|---|---|---|
ProThera Biologics, Inc.
 ProThera Biologics, Inc. Pharmaceuticals: OtherHealth Technology ProThera Biologics, Inc. develops diagnostics and therapeutics treatments. The firm’s products include replenish the deficiency in patients, significantly reduce inflammation and target the host's dysregulated response. The company was founded by Yow-Pin Lim and Douglas C. Hixson in 2002 and is headquartered in Providence, RI. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Richard A. Andrews
| Società | Posizione | Fine |
|---|---|---|
| AZITRA, INC. | Fondatore | 04/05/2021 |
Vasca, Inc.
 Vasca, Inc. Medical SpecialtiesHealth Technology Vasca, Inc. develops access and related technologies. It manufactures and markets life site hemodialysis access system technologies to improve the quality of patient care in the United States. The company was founded by Jeffrey H. Burbank in April 1996 and is headquartered in Tewksbury, MA. | Corporate Officer/Principal | - |
ProThera Biologics, Inc.
ProThera Biologics, Inc. Pharmaceuticals: OtherHealth Technology ProThera Biologics, Inc. develops diagnostics and therapeutics treatments. The firm’s products include replenish the deficiency in patients, significantly reduce inflammation and target the host's dysregulated response. The company was founded by Yow-Pin Lim and Douglas C. Hixson in 2002 and is headquartered in Providence, RI. | Corporate Officer/Principal | - |
Thrasos Therapeutics, Inc.
 Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Amministratore Delegato | - |
RenaMed Biologics, Inc.
 RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI. | Fondatore | - |
Formazione di Richard A. Andrews
| Hobart & William Smith Colleges | Undergraduate Degree |
| Purdue University | Graduate Degree |
| Massachusetts Institute of Technology | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AZITRA, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
RenaMed Biologics, Inc.
RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI. | Health Services |
ProThera Biologics, Inc.
ProThera Biologics, Inc. Pharmaceuticals: OtherHealth Technology ProThera Biologics, Inc. develops diagnostics and therapeutics treatments. The firm’s products include replenish the deficiency in patients, significantly reduce inflammation and target the host's dysregulated response. The company was founded by Yow-Pin Lim and Douglas C. Hixson in 2002 and is headquartered in Providence, RI. | Health Technology |
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Health Technology |
Vasca, Inc.
Vasca, Inc. Medical SpecialtiesHealth Technology Vasca, Inc. develops access and related technologies. It manufactures and markets life site hemodialysis access system technologies to improve the quality of patient care in the United States. The company was founded by Jeffrey H. Burbank in April 1996 and is headquartered in Tewksbury, MA. | Health Technology |
- Borsa valori
- Insiders
- Richard A. Andrews
